This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buffon, A. Articles by Maseri, A. Search for Related Content PubMed PubMed Citation Articles by Buffon, A. Articles by Maseri, A.

CLINICAL STUDIES

Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia

Antonino Buffon, MD^*, Stefano A. Santini, MD, Vito Ramazzotti, MD^*, Stefano Rigattieri, MD^*, Giovanna Liuzzo, MD^*, Luigi M. Biasucci, MD, FACC^*, Filippo Crea, MD, FACC^*, Bruno Giardina, PhD and Attilio Maseri, MD, FACC^*

^* Istituto di Cardiologia, Universita’ Cattolica del Sacro Cuore, 00168 Roma, Italy
Istituto di Chimica Biologica, Universita’ Cattolica del Sacro Cuore, 00168 Roma, Italy
Istituto di Chimica e Chimica Clinica, Universita’ Cattolica del Sacro Cuore, 00168 Roma, Italy

Manuscript received December 15, 1998; revised manuscript received September 20, 1999, accepted November 3, 1999.

Reprint requests and correspondence: Dr. Antonino Buffon, Istituto di Cardiologia, Universita’ Cattolica del Sacro Cuore, Largo Gemelli 8, 00168 Rome, Italy

OBJECTIVES

We sought to investigate whether a brief episode of myocardial ischemia produces a detectable cardiac oxidative stress in patients undergoing elective coronary angioplasty (PTCA).

BACKGROUND

Although cardiac oxidative stress has been clearly demonstrated in experimental models of ischemia-reperfusion, its presence in patients after transient myocardial ischemia is still unclear.

METHODS

In order to evaluate oxidative stress in ischemic cardiac regions, plasma conjugated dienes (CD), lipid hydroperoxides (ROOHs) and total antioxidant capacity (TRAP), independent indexes of oxidative stress, were measured in the aorta and great cardiac vein (GCV) before (t₀), 1, (t₁), 5 (t₅) and 15 min (t₁₅) after first balloon inflation in 15 patients undergoing PTCA on left anterior descending coronary artery (Group 1); six patients with right coronary artery stenosis (Group 2), which is not drained by the GCV, were studied as controls.

RESULTS

In Group 1 at baseline, CD and ROOHs levels were higher in GCV than in aorta (p < 0.01 for both), and TRAP levels were lower (p < 0.01). Aortic levels of CD, ROOHs and TRAP did not change at any time after t₀; venous levels of CD and ROOHs levels markedly increased at t₁, at t₅ and remained elevated at t₁₅ (p < 0.01 for all comparisons vs. t₀); venous levels of TRAP decreased at t₁ and t₅ (p < 0.01 vs. t₀) and returned to normal at t₁₅. In Group 2, CD, ROOHs and TRAP levels were similar in the aorta and GCV and did not change throughout the study.

CONCLUSIONS

Short episodes of myocardial ischemia during PTCA induce a sustained oxidative stress, which is detectable in the venous effluent of reperfused myocardium.

Abbreviations and Acronyms   A.U. = arbitrary units   CD = conjugated dienes   GCV = great cardiac vein   LAD = left anterior descending coronary artery   PTCA = percutaneous transluminal coronary angioplasty   RCA = right coronary artery   ROOHs = hydroperoxides   ROS = reactive oxygen species   TRAP = plasma antioxidant capacity   t0 = before first balloon inflation   t1 = 1 min after first balloon deflation   t5 = 5 min after first balloon deflation   t15 = 15 min after first balloon deflation

This article has been cited by other articles:

				M. F. Walter, R. F. Jacob, R. E. Bjork, B. Jeffers, J. Buch, Y. Mizuno, R. P. Mason, and on behalf of the PREVENT Investigators Circulating Lipid Hydroperoxides Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease: The PREVENT Study J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1196 - 1202. [Abstract] [Full Text] [PDF]

				M. Gomaraschi, L. Calabresi, G. Rossoni, S. Iametti, G. Franceschini, J. A. Stonik, and A. T. Remaley Anti-Inflammatory and Cardioprotective Activities of Synthetic High-Density Lipoprotein Containing Apolipoprotein A-I Mimetic Peptides J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 776 - 783. [Abstract] [Full Text] [PDF]

				E. Giannitsis and H. A. Katus Mirror, mirror on the wall: the quest for the earliest marker of myocardial ischaemia Eur. Heart J., November 2, 2005; 26(22): 2349 - 2350. [Full Text] [PDF]

				J.P. Ottervanger, P. Armstrong, E.S. Barnathan, E. Boersma, J.S. Cooper, E.M. Ohman, S. James, L. Wallentin, M.L. Simoons, and For the GUSTO IV-ACS Investigators Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS Eur. Heart J., September 1, 2004; 25(17): 1494 - 1501. [Abstract] [Full Text] [PDF]

				S. Tsimikas, H. K. Lau, K.-R. Han, B. Shortal, E. R. Miller, A. Segev, L. K. Curtiss, J. L. Witztum, and B. H. Strauss Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein Circulation, June 29, 2004; 109(25): 3164 - 3170. [Abstract] [Full Text] [PDF]

				M. G. Andreassi, N. Botto, A. Rizza, M. G. Colombo, C. Palmieri, S. Berti, S. Manfredi, S. Masetti, A. Clerico, and A. Biagini Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty J. Am. Coll. Cardiol., September 4, 2002; 40(5): 862 - 868. [Abstract] [Full Text] [PDF]

				S. Setoguchi, M. Mohri, H. Shimokawa, and A. Takeshita Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease J. Am. Coll. Cardiol., August 1, 2001; 38(2): 493 - 498. [Abstract] [Full Text] [PDF]

				A. Buffon, S. Rigattieri, S. A. Santini, V. Ramazzotti, F. Crea, B. Giardina, and A. Maseri Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2627 - H2633. [Abstract] [Full Text] [PDF]